The global digital therapeutics market size was valued at $2.24 billion in 2018 and is expected to reach $9.64 billion by 2026 with a CAGR of 19.9% during the forecast period.

Digital therapeutics is a subdivision of digital health, and not all digital health solutions are digital therapeutics. The difference between digital health and digital therapeutics is based on the clinical outcomes for patients. For instance, digital therapeutics does not include consumer health-oriented technologies such as step-counters and calorie-counters. It’s a new class of healthcare products that uses digital technology to prevent, manage, or treat medical conditions. In addition, it utilizes digital health technologies to treat a psychological condition. Hence, these aforementioned factors help in increasing the global digital therapeutics market share across the world.

Get more information on this report : Request Sample Pages

The demand for global digital therapeutics is increasing due to increase in adoption of smartphones and tablets, coupled with healthcare apps; growth in need to control healthcare costs; and rise in incidence of chronic diseases. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the digital therapeutics market growth. On the contrary, high growth opportunities in untapped markets are expected to provide significant profitable opportunities for manufacturers in the digital therapeutics industry.

Application Segment Review

On the basis of application, the digital therapeutics market is segmented into diabetes, obesity, cardiovascular disease, central nervous system disease, respiratory disease, smoking cessation, gastrointestinal disorder, and others. The diabetes segment was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period, owing to high prevalence of diabetes. In addition, demand for cost-effective healthcare options and highest comparative prevalence rates for diabetes are observed in North America, the Middle East, and North Africa, which further boosts the demand for digital therapeutics among diabetic patients in these regions. However, the obesity segment is projected to exhibit the highest growth during the forecast period. This is attributed to increasing number of overweight populations thereby, increasing number of chronic diseases due to obesity. In addition, better accessibility of digital therapeutics software application help patients to maintain their proper diet as well as track health data and daily physical activities. Moreover, the software application provides regular online assistance from certified doctors, which is expected to help in reducing the prevalence of obesity in the future. Furthermore, several companies have launched a variety of digital therapeutics products. For example, in 2017, Oxil launched an app to tackle increasing cases of obesity among youth. Moreover, Azumio provides fitness buddy mobile app that offers largest exercise database, which helps reduce obesity. The analysis done by Noom Inc. demonstrated that 78% of users lost weight with its mobile health coaching solutions.

Digital Therapeutics Market By Application Your browser does not support the canvas element. Diabetes holds the dominant position in 2018 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Product Segment Review

Depending on the product, the digital therapeutics market is categorized into software and devices. The software segment is projected to exhibit the highest growth during the forecast period. This is attributed to the rise in demand for reducing healthcare costs across the world. This gives immense opportunities to developers to use the existing software and develop new and advanced features, to make them more effective and affordable. Thus, is anticipated to help in increasing the digital therapeutics market size in the future.

Digital Therapeutics Market By Product Your browser does not support the canvas element. Software segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Region Segment Review

Region wise, the digital therapeutics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2018, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in geriatric population, rise in incidence of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure.

Digital Therapeutics Market By Region 2026 North America Europe Asia-pacific Lamea Asia-Pacific region would exhibit the highest CAGR of 21.7% during 2019-2026.

Get more information on this report : Request Sample Pages

The report provides a comprehensive analysis of the key players operating in the global digital therapeutics market, namely 2MORROW, Inc., Fitbit, Inc. (Twine Health, Inc.), Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc. The other players in the value chain include (profiles not included in the report) Canary Health Inc., Mango Health Inc., Noom, Inc., and Dthera Sciences.

Key Benefits for Stakeholders:

This report provides a detailed quantitative analysis of the current digital therapeutics market trends and forecast estimations from 2018 to 2026, which assists to identify the prevailing market opportunities.

An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

A comprehensive analysis of factors that drive and restrain the growth of the global is provided.

Region-wise and country-wise market conditions are comprehensively analyzed in this report.

The projections in this report are made by analyzing the current trends and future market potential from 2019 to 2026, in terms of value.

An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

Key market players within the digital therapeutics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of global digital therapeutics market.

Key Market Segments:

By Application

Diabetes

Obesity

Cardiovascular Disease (CVD)

Central Nervous System (CNS) Disease

Respiratory Disease

Smoking Cessation

Gastrointestinal Disorder (GID)

Others

By Product Type

Software

Device

By Sales Channel

Business-to-Business (B2B) Employer Healthcare Provider Others

Business-to-Consumer (B2C) Patient Caregiver



By Region